USPTO serial 88404956
CBCB-METHOD
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 9, 2021
- Examiner
- DICKSON, RACHAEL
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with CBCB-METHOD?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*
Plus Government fees of $975
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Devasena Reddy
Devasena Reddy HM LAW GROUP LLP5655 Silver Creek Valley Road,#850San Jose, CA 95138Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | chemical preparations for industrial and scientific use; biological preparations for industrial and scientific use, all the aforesaid goods are for use only with non-consumable, non-medicinal, and non-therapeutic goods derived solely from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis | ACTIVE | — |
| 005 | Fungicides, herbicides, namely, antibacterial; flour for pharmaceutical purposes; analgesics; local analgesics; antipyretic analgesics; anti-inflammatory pain patches; analgesic creams; analgesics; universal medical pain-relieving creams; Analgesic pharmaceutical effervescent preparations; Pharmaceutical preparations and substances with analgesic properties; Laxatives; Laxative tablets; Antibiotics; Antiseptics; Veterinary medicinal products, namely, veterinary vaccines; Bath salts for medical purposes; Bath additives in the nature of bath salts for medical purposes; tree bark for pharmaceutical purposes for the treatment of gout; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; biological preparations for medical purposes for the treatment of cancer; biological preparations for veterinary purposes, namely, veterinary vaccines; Dietary foods for medical purposes; protein supplement preparations for medical purposes; enzymes for medical purposes; enzyme preparations for medical purposes; fats for medical purposes; freeze-dried foodstuffs for medical purposes; homogenised foodstuffs for medical purposes; allergy and diet capsules for medical purposes; allergy and diet capsules for pharmaceutical purposes; chewing gum for medical purposes; mineral waters for medical purposes; mineral water salts for medicinal purposes; wipes soaked with pharmaceutical lotions; mouthwashes for medical purposes; food supplements; Nerve-attenuating pharmaceutical preparations; therapeutic medicated bath preparations; all the aforesaid goods not containing any cannabis, hemp or CBD | ACTIVE | — |
| 042 | pharmaceutical research services of a development and research company in the fields of biotechnology, pharmacy, medicine, diagnostics and chemistry and information technology; production, development of biotechnological, pharmaceutical and diagnostic processes and products; Development of processes for the production of chemical substances; chemical laboratory services; chemical technical consultancy; scientific and technological services and research and related design services in the field of pharmaceuticals; industrial analysis and research services to assure compliance with industry standards; design and development of computer software; development of pharmaceutical test methods; product design and development; development of industrial products; pharmaceutical research and development services; development of industrial engineering processes; scientific research and development; industrial pharmaceutical drug development services, aforesaid services are for use only with non-consumable, non-medicinal, and non-therapeutic goods derived solely from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by SYNBIONIK GMBH
- Other trademarks owned by Farmako GmbH
- Other trademarks owned by SYNBIONIK GMBH
- Other trademarks owned by SYNBIONIK GMBH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named CBCB-METHOD
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 9, 2026 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Apr 15, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 15, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 15, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 9, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 22, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 22, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 2, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 19, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 19, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 19, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 19, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 19, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 11, 2020 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Nov 11, 2020 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Nov 11, 2020 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Oct 19, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 19, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 19, 2020 | ALIE | ASSIGNED TO LIE | — |
| Sep 3, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 28, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 28, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 28, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 16, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 27, 2019 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| May 14, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| May 14, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 30, 2019 | NWAP | NEW APPLICATION ENTERED | — |